Skip to content

CIK 0000859737

HOLX HOLOGIC INC

Insider trading from SEC Form 4. Last filing Feb 28, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
17
with a Form 4 at this company

Signals

Open-market buys and sells at HOLOGIC INC, scored.

ScoreSideInsiderValueSharesHoldings changePrice contextFiled
40ModeratesellMitchell Essex D
Chief Operating Officer
$1.9M24,856-47%-

Congressional trades

2 trades in HOLX disclosed by members of Congress under the STOCK Act. All congressional trades.

MemberTypeAssetAmountTradedFiled
Laura Friedman
House · D-CA
Partial saleHOLX
Hologic, Inc. - Common Stock
$1,001 to $15kApr 8, 2026
36 days after the trade
Gilbert Ray Cisneros, Jr.
House · D-CA
SaleHOLX
Hologic, Inc. - Common Stock
$1,001 to $15kMar 31, 2025
7 days after the trade

Transactions

The last 77 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Feb 26, 2025Stamoulis Christiana
director
AGrant or award
Common Stock
+1,864--47,336Feb 28, 2025
Feb 26, 2025Dockendorff Charles J
director
AGrant or award
Common Stock
+1,864--3,436Feb 28, 2025
Feb 26, 2025Wendell Amy McBride
director
AGrant or award
Common Stock
+1,864--22,594Feb 28, 2025
Feb 26, 2025Stewart Stacey D.
director
AGrant or award
Common Stock
+1,864--5,168Feb 28, 2025
Feb 26, 2025Mohtashami Nanaz
director
AGrant or award
Common Stock
+1,864--4,181Feb 28, 2025
Feb 26, 2025Madaus Martin D
director
AGrant or award
Common Stock
+1,864--2,206Feb 28, 2025
Feb 26, 2025HANTSON LUDWIG
director
AGrant or award
Common Stock
+1,864--12,956Feb 28, 2025
Feb 26, 2025Madaus Martin D
director
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+5,535$0.00$05,535Feb 28, 2025
Feb 26, 2025Mohtashami Nanaz
director
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+5,535$0.00$05,535Feb 28, 2025
Feb 26, 2025Stamoulis Christiana
director
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+5,535$0.00$05,535Feb 28, 2025
Feb 26, 2025HANTSON LUDWIG
director
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+5,535$0.00$05,535Feb 28, 2025
Feb 26, 2025Stewart Stacey D.
director
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+5,535$0.00$05,535Feb 28, 2025
Feb 26, 2025Wendell Amy McBride
director
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+5,535$0.00$05,535Feb 28, 2025
Feb 26, 2025Dockendorff Charles J
director
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+5,535$0.00$05,535Feb 28, 2025
Feb 10, 2025Horvath Mark W.
Div. Pres., Breast & Skeletal
AGrant or award
Common Stock
+958--7,057Feb 12, 2025
Feb 10, 2025Horvath Mark W.
Div. Pres., Breast & Skeletal
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+2,844$0.00$02,844Feb 12, 2025
Dec 13, 2024Schnittker Brandon
Div. President, GYN Surgical
FTax withholding
Common Stock
-90$73.65$6,6296,163Dec 17, 2024
Dec 9, 2024Madaus Martin D
director
AGrant or award
Common Stock
+342--342Dec 11, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Common Stock
+1,956$40.97$80k31,867Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Common Stock
+4,526$45.61$206k36,393Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Common Stock
+7,505$68.35$513k43,898Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Common Stock
+8,915$71.13$634k52,813Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
SOpen-market sale
Common Stock
-24,856$76.34$1.9M27,957Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Non-qualified Stock Option (Right to Buy)derivative
-1,956$0.00$00Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Non-qualified Stock Option (Right to Buy)derivative
-4,526$0.00$00Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Non-qualified Stock Option (Right to Buy)derivative
-7,505$0.00$00Dec 6, 2024
Dec 4, 2024Mitchell Essex D
Chief Operating Officer
MOption exercise
Non-qualified Stock Option (Right to Buy)derivative
-8,915$0.00$02,972Dec 6, 2024
Nov 14, 2024Anderson Erik S
Div. Pres., Breast & Skeletal
FTax withholding
Common Stock
-390$77.54$30k23,231Nov 18, 2024
Nov 14, 2024MACMILLAN STEPHEN P
Chairman, President and CEO
FTax withholding
Common Stock
-6,860$77.54$532k1,234,278Nov 18, 2024
Nov 14, 2024Verstreken Jan
Group President, International
FTax withholding
Common Stock
-630$77.54$49k103,814Nov 18, 2024
Nov 14, 2024Schnittker Brandon
Div. President, GYN Surgical
FTax withholding
Common Stock
-178$77.54$14k6,253Nov 18, 2024
Nov 14, 2024Schneiders Jennifer M
President, Diag. Solutions
FTax withholding
Common Stock
-507$77.54$39k12,096Nov 18, 2024
Nov 14, 2024Mitchell Essex D
Chief Operating Officer
FTax withholding
Common Stock
-1,341$77.54$104k29,911Nov 18, 2024
Nov 14, 2024Griffin John M.
General Counsel
FTax withholding
Common Stock
-1,120$77.54$87k182,514Nov 18, 2024
Nov 14, 2024COHN BENJAMIN JORDAN
Principal Accounting Officer
FTax withholding
Common Stock
-110$77.54$8,52911,250Nov 18, 2024
Nov 14, 2024Oberton Karleen Marie
Chief Financial Officer
FTax withholding
Common Stock
-1,332$77.54$103k102,108Nov 18, 2024
Nov 7, 2024Griffin John M.
General Counsel
FTax withholding
Common Stock
-592$79.29$47k186,635Nov 12, 2024
Nov 7, 2024Anderson Erik S
Div. Pres., Breast & Skeletal
FTax withholding
Common Stock
-344$79.29$27k20,295Nov 12, 2024
Nov 7, 2024COHN BENJAMIN JORDAN
Principal Accounting Officer
FTax withholding
Common Stock
-106$79.29$8,40510,370Nov 12, 2024
Nov 7, 2024Mitchell Essex D
Chief Operating Officer
FTax withholding
Common Stock
-422$79.29$33k24,614Nov 12, 2024
Nov 7, 2024Oberton Karleen Marie
Chief Financial Officer
FTax withholding
Common Stock
-1,161$79.29$92k106,591Nov 12, 2024
Nov 7, 2024Schneiders Jennifer M
President, Diag. Solutions
FTax withholding
Common Stock
-157$79.29$12k6,430Nov 12, 2024
Nov 7, 2024Schnittker Brandon
Div. President, GYN Surgical
FTax withholding
Common Stock
-138$79.29$11k3,597Nov 12, 2024
Nov 7, 2024Verstreken Jan
Group President, International
FTax withholding
Common Stock
-601$79.29$48k103,074Nov 12, 2024
Nov 7, 2024MACMILLAN STEPHEN P
Chairman, President and CEO
FTax withholding
Common Stock
-6,214$79.29$493k1,269,908Nov 12, 2024
Nov 8, 2024MACMILLAN STEPHEN P
Chairman, President and CEO
FTax withholding
Common Stock
-68,447$78.76$5.4M1,201,461Nov 12, 2024
Nov 8, 2024Verstreken Jan
Group President, International
FTax withholding
Common Stock
-4,928$78.76$388k98,146Nov 12, 2024
Nov 11, 2024Schnittker Brandon
Div. President, GYN Surgical
AGrant or award
Common Stock
+2,834--6,431Nov 12, 2024
Nov 8, 2024Schneiders Jennifer M
President, Diag. Solutions
FTax withholding
Common Stock
-125$78.76$9,8456,305Nov 12, 2024
Nov 8, 2024Oberton Karleen Marie
Chief Financial Officer
FTax withholding
Common Stock
-12,598$78.76$992k93,993Nov 12, 2024
Nov 8, 2024Mitchell Essex D
Chief Operating Officer
FTax withholding
Common Stock
-4,383$78.76$345k20,231Nov 12, 2024
Nov 8, 2024Griffin John M.
General Counsel
FTax withholding
Common Stock
-9,299$78.76$732k177,336Nov 12, 2024
Nov 8, 2024COHN BENJAMIN JORDAN
Principal Accounting Officer
FTax withholding
Common Stock
-190$78.76$15k10,180Nov 12, 2024
Nov 8, 2024Anderson Erik S
Div. Pres., Breast & Skeletal
FTax withholding
Common Stock
-1,397$78.76$110k18,898Nov 12, 2024
Nov 11, 2024COHN BENJAMIN JORDAN
Principal Accounting Officer
AGrant or award
Common Stock
+1,180--11,360Nov 12, 2024
Nov 11, 2024MACMILLAN STEPHEN P
Chairman, President and CEO
AGrant or award
Common Stock
+39,677--1,241,138Nov 12, 2024
Nov 11, 2024Anderson Erik S
Div. Pres., Breast & Skeletal
AGrant or award
Common Stock
+4,723--23,621Nov 12, 2024
Nov 11, 2024Verstreken Jan
Group President, International
AGrant or award
Common Stock
+6,298--104,444Nov 12, 2024
Nov 11, 2024Schnittker Brandon
Div. President, GYN Surgical
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+8,414$0.00$08,414Nov 12, 2024
Nov 11, 2024Schneiders Jennifer M
President, Diag. Solutions
AGrant or award
Common Stock
+6,298--12,603Nov 12, 2024
Nov 11, 2024Oberton Karleen Marie
Chief Financial Officer
AGrant or award
Common Stock
+9,447--103,440Nov 12, 2024
Nov 11, 2024Griffin John M.
General Counsel
AGrant or award
Common Stock
+6,298--183,634Nov 12, 2024
Nov 11, 2024Mitchell Essex D
Chief Operating Officer
AGrant or award
Common Stock
+11,021--31,252Nov 12, 2024
Nov 11, 2024Griffin John M.
General Counsel
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+18,698$0.00$018,698Nov 12, 2024
Nov 11, 2024Anderson Erik S
Div. Pres., Breast & Skeletal
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+14,023$0.00$014,023Nov 12, 2024
Nov 11, 2024COHN BENJAMIN JORDAN
Principal Accounting Officer
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+3,505$0.00$03,505Nov 12, 2024
Nov 11, 2024Mitchell Essex D
Chief Operating Officer
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+32,722$0.00$032,722Nov 12, 2024
Nov 11, 2024Oberton Karleen Marie
Chief Financial Officer
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+28,047$0.00$028,047Nov 12, 2024
Nov 11, 2024Schneiders Jennifer M
President, Diag. Solutions
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+18,698$0.00$018,698Nov 12, 2024
Nov 11, 2024Verstreken Jan
Group President, International
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+18,698$0.00$018,698Nov 12, 2024
Nov 11, 2024MACMILLAN STEPHEN P
Chairman, President and CEO
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+117,801$0.00$0117,801Nov 12, 2024
Nov 5, 2024Anderson Erik S
Div. Pres., Breast & Skeletal
AGrant or award
Common Stock
+4,149--20,639Nov 7, 2024
Nov 5, 2024Griffin John M.
General Counsel
AGrant or award
Common Stock
+20,746--187,227Nov 7, 2024
Nov 5, 2024Mitchell Essex D
Chief Operating Officer
AGrant or award
Common Stock
+11,854--25,036Nov 7, 2024
Nov 5, 2024Oberton Karleen Marie
Chief Financial Officer
AGrant or award
Common Stock
+23,710--107,752Nov 7, 2024
Nov 5, 2024Verstreken Jan
Group President, International
AGrant or award
Common Stock
+17,780--103,675Nov 7, 2024
Nov 5, 2024MACMILLAN STEPHEN P
Chairman, President and CEO
AGrant or award
Common Stock
+118,560--1,276,122Nov 7, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

HOLX insider trading: HOLOGIC INC | InsiderTell